Literature DB >> 11317357

Spectrum of germline RB1 gene mutations in Spanish retinoblastoma patients: Phenotypic and molecular epidemiological implications.

J Alonso1, P García-Miguel, J Abelairas, M Mendiola, E Sarret, M T Vendrell, A Navajas, A Pestaña.   

Abstract

Mutation analysis of retinoblastoma is considered important for genetic counseling purposes, as well as for understanding the molecular mechanisms leading to tumors with different degrees of penetrance or expressivity. In the course of an analysis of 43 hereditary retinoblastoma Spanish patients and kindred, using direct PCR sequencing, we have observed 29 mutations; most of them (62%) have not been reported previously. Of the mutations, 69% correspond to nonsense mutations (mainly CpG transitions) and frameshifts, with the expected outcome of a truncated Rb protein that lacks the functional pocket domains and tail. The remainder corresponds to splicing mutations, most of them (62%) targeted to invariant nucleotides, with the predicted consequence of out of frame exon skipping. Two of the splicing mutations in our study were found associated to families with a low-penetrance phenotype. Additionally, most of the mutations affecting splice junctions corresponded to retinoblastoma cases of either sporadic or hereditary nature with delayed onset (32 months on average). In contrast, most of the nonsense and frameshift mutations are associated with an early age at diagnosis (8.7 months on average). These differences are discussed in the context of the relationships between genotype and low expressivity phenotype. The differences in the spectrum of RB1 mutations found in this and other European surveys are also discussed in the context of alternate DNA methylation and mismatch repair phenotypes. Copyright 2001 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11317357     DOI: 10.1002/humu.1117

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  21 in total

1.  Ethnic variations of a retinoblastoma susceptibility gene (RB1) polymorphism in eight Asian populations.

Authors:  Priya Kadam-Pai; Xin-Yi Su; Jasmin Jiji Miranda; Agustinus Soemantri; Nilmani Saha; Chew-Kiat Heng; Poh-San Lai
Journal:  J Genet       Date:  2003 Apr-Aug       Impact factor: 1.166

2.  Pattern of sequence variation across 213 environmental response genes.

Authors:  Robert J Livingston; Andrew von Niederhausern; Anil G Jegga; Dana C Crawford; Christopher S Carlson; Mark J Rieder; Sivakumar Gowrisankar; Bruce J Aronow; Robert B Weiss; Deborah A Nickerson
Journal:  Genome Res       Date:  2004-09-13       Impact factor: 9.043

3.  Association Between Genotype and Phenotype in Consecutive Unrelated Individuals With Retinoblastoma.

Authors:  Flore Salviat; Marion Gauthier-Villars; Matthieu Carton; Nathalie Cassoux; Livia Lumbroso-Le Rouic; Catherine Dehainault; Christine Levy; Lisa Golmard; Isabelle Aerts; François Doz; Fidéline Bonnet-Serrano; Stéphanie Hayek; Alexia Savignoni; Dominique Stoppa-Lyonnet; Claude Houdayer
Journal:  JAMA Ophthalmol       Date:  2020-08-01       Impact factor: 7.389

4.  New RB1 oncogenic mutations and intronic polymorphisms in Serbian retinoblastoma patients: genetic counseling implications.

Authors:  Milica Kontic; Iciar Palacios; Ángelo Gámez; Isabel Camino; Zoran Latkovic; Dejan Rasic; Vera Krstic; Vera Bunjevacki; Javier Alonso; Ángel Pestaña
Journal:  J Hum Genet       Date:  2006-09-14       Impact factor: 3.172

5.  Mutational analysis of the RB1 gene and the inheritance patterns of retinoblastoma in Jordan.

Authors:  Yacoub A Yousef; Abdelghani Tbakhi; Maysa Al-Hussaini; Ibrahim AlNawaiseh; Ala Saab; Amal Afifi; Maysa Naji; Mona Mohammad; Rasha Deebajah; Imad Jaradat; Iyad Sultan; Mustafa Mehyar
Journal:  Fam Cancer       Date:  2018-04       Impact factor: 2.375

Review 6.  Nonsense-mediated decay in genetic disease: friend or foe?

Authors:  Jake N Miller; David A Pearce
Journal:  Mutat Res Rev Mutat Res       Date:  2014-05-28       Impact factor: 5.657

7.  Tissue-specific reduction in splicing efficiency of IKBKAP due to the major mutation associated with familial dysautonomia.

Authors:  Math P Cuajungco; Maire Leyne; James Mull; Sandra P Gill; Weining Lu; David Zagzag; Felicia B Axelrod; Channa Maayan; James F Gusella; Susan A Slaugenhaupt
Journal:  Am J Hum Genet       Date:  2003-02-06       Impact factor: 11.025

Review 8.  Molecular biology of retinoblastoma.

Authors:  C Sábado Alvarez
Journal:  Clin Transl Oncol       Date:  2008-07       Impact factor: 3.405

9.  A comprehensive, sensitive and economical approach for the detection of mutations in the RB1 gene in retinoblastoma.

Authors:  Vidya Latha Parsam; Chitra Kannabiran; Santosh Honavar; Geeta K Vemuganti; Mohammad Javed Ali
Journal:  J Genet       Date:  2009-12       Impact factor: 1.166

10.  Tocotrienol Treatment in Familial Dysautonomia: Open-Label Pilot Study.

Authors:  David Cheishvili; Channa Maayan; Naama Holzer; Jeanna Tsenter; Elad Lax; Sophie Petropoulos; Aharon Razin
Journal:  J Mol Neurosci       Date:  2016-04-30       Impact factor: 3.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.